Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
CONy 2023
ACTRIMS 2023
ISC 2023
EHC 2022
AES 2022
WSC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Mar Tintoré
3:10
Natalizumab: a strategy for immunization to avoid delays of treatment onset in highly active MS
Mar Tintoré
• 4 Nov 2022
1:53
The ECTRIMS 2022 Event for People with MS
Mar Tintoré
• 4 Nov 2022
3:10
Biomarkers of disease activity and treatment response in MS
Mar Tintoré
• 4 Nov 2022
1:39
Addressing PIRA and PROMs in clinical practice
Mar Tintoré
• 4 Nov 2022
7:37
Key updates and research focuses at ECTRIMS 2022
Mar Tintoré
• 4 Nov 2022
3:14
Limitations of the current multiple sclerosis classification
Mar Tintoré
• 4 Oct 2021
1:50
Relapse-independent progression in multiple sclerosis
Mar Tintoré
• 4 Oct 2021
2:11
Incorporating new measures to detect silent progression in multiple sclerosis
Mar Tintoré
• 4 Oct 2021
4:03
Key areas of research in multiple sclerosis
Mar Tintoré
• 4 Oct 2021
2:39
Barcelona_BRS to predict long-term prognosis in MS patients
Mar Tintoré
• 4 Oct 2021
2:12
Future challenges for MS research: progressive disease
Mar Tintoré
• 7 Jun 2021
5:31
S1P receptor modulators in the treatment of MS
Mar Tintoré
• 7 Jun 2021
12:15
How to individualize MS treatment decisions?
Mar Tintoré
• 7 Jun 2021